Cigniti Technologies [CIGNITITEC] vs Nucleus Software [NUCLEUS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Cigniti Technologies wins in 14 metrics, Nucleus Software wins in 5 metrics, with 0 ties. Cigniti Technologies appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricCigniti TechnologiesNucleus SoftwareBetter
P/E Ratio (TTM)16.2415.72Nucleus Software
Price-to-Book Ratio4.323.23Nucleus Software
Debt-to-Equity Ratio2.900.25Nucleus Software
PEG Ratio0.030.85Cigniti Technologies
EV/EBITDA11.6513.42Cigniti Technologies
Profit Margin (TTM)12.29%19.66%Nucleus Software
Operating Margin (TTM)15.24%14.05%Cigniti Technologies
EBITDA Margin (TTM)15.24%14.05%Cigniti Technologies
Return on Equity20.78%20.02%Cigniti Technologies
Return on Assets (TTM)16.15%14.14%Cigniti Technologies
Free Cash Flow (TTM)$1.46B$1.36BCigniti Technologies
Dividend YieldN/A1.08%N/A
1-Year Return9.39%-20.11%Cigniti Technologies
Price-to-Sales Ratio (TTM)1.993.09Cigniti Technologies
Enterprise Value$38.77B$22.85BCigniti Technologies
EV/Revenue Ratio1.862.67Cigniti Technologies
Gross Profit Margin (TTM)44.53%33.15%Cigniti Technologies
Revenue per Share (TTM)$754$323Cigniti Technologies
Earnings per Share (Diluted)$92.92$63.52Cigniti Technologies
Beta (Stock Volatility)-0.26-0.33Nucleus Software
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Cigniti Technologies vs Nucleus Software Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Cigniti Technologies-3.12%-12.84%-9.40%-14.06%4.66%-13.48%
Nucleus Software-0.50%-5.94%-4.05%-15.15%21.79%-3.31%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Cigniti Technologies9.39%172.86%256.82%270.62%222.53%222.53%
Nucleus Software-20.11%153.22%48.92%331.11%627.10%613.40%

News Based Sentiment: Cigniti Technologies vs Nucleus Software

Cigniti Technologies

News based Sentiment: POSITIVE

Cigniti Technologies delivered impressive financial results in Q1 FY26 and for the full fiscal year 2025-26, demonstrating strong growth and profitability. While the potential merger with Coforge Limited adds a layer of uncertainty, the company's solid performance and attractive valuation metrics make it a compelling investment opportunity.

View Cigniti Technologies News Sentiment Analysis

Nucleus Software

News based Sentiment: MIXED

September presented a mixed bag for Nucleus Software, with positive business developments like the Finnovex award and Saarathi Finance partnership being significantly offset by the SEBI penalty for insider trading. While long-term performance remains strong, the governance concerns create uncertainty and require close monitoring, making this a month of both opportunity and risk.

View Nucleus Software News Sentiment Analysis

Performance & Financial Health Analysis: Cigniti Technologies vs Nucleus Software

MetricCIGNITITECNUCLEUS
Market Information
Market Cap i₹41.06B₹26.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i71,64613,612
90 Day Avg. Volume i63,40113,347
Last Close₹1,461.80₹998.40
52 Week Range₹1,033.25 - ₹1,970.00₹725.00 - ₹1,378.00
% from 52W High-25.80%-27.55%
All-Time High₹1,970.00 (Dec 16, 2024)₹1,787.50 (Jan 22, 2024)
% from All-Time High-25.80%-44.15%
Growth Metrics
Quarterly Revenue Growth0.14%0.11%
Quarterly Earnings Growth5.27%0.17%
Financial Health
Profit Margin (TTM) i0.12%0.20%
Operating Margin (TTM) i0.15%0.14%
Return on Equity (TTM) i0.21%0.20%
Debt to Equity (MRQ) i2.900.25
Cash & Liquidity
Book Value per Share (MRQ)₹349.61₹309.29
Cash per Share (MRQ)₹145.45₹136.33
Operating Cash Flow (TTM) i₹974.04M₹2.28B
Levered Free Cash Flow (TTM) i₹2.00B₹1.63B
Dividends
Last 12-Month Dividend Yield iN/A1.08%
Last 12-Month Dividend i₹0.00₹12.50

Valuation & Enterprise Metrics Analysis: Cigniti Technologies vs Nucleus Software

MetricCIGNITITECNUCLEUS
Price Ratios
P/E Ratio (TTM) i16.2415.72
Forward P/E iN/A35.47
PEG Ratio i0.030.85
Price to Sales (TTM) i1.993.09
Price to Book (MRQ) i4.323.23
Market Capitalization
Market Capitalization i₹41.06B₹26.41B
Enterprise Value i₹38.77B₹22.85B
Enterprise Value Metrics
Enterprise to Revenue i1.862.67
Enterprise to EBITDA i11.6513.42
Risk & Other Metrics
Beta i-0.26-0.33
Book Value per Share (MRQ) i₹349.61₹309.29

Financial Statements Comparison: Cigniti Technologies vs Nucleus Software

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CIGNITITECNUCLEUS
Revenue/Sales i₹5.34B₹2.18B
Cost of Goods Sold i₹2.96B₹1.46B
Gross Profit i₹2.38B₹721.70M
Research & Development iN/AN/A
Operating Income (EBIT) i₹814.00M₹305.80M
EBITDA i₹972.00M₹519.40M
Pre-Tax Income i₹889.00M₹483.00M
Income Tax i₹230.00M₹131.00M
Net Income (Profit) i₹659.00M₹352.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CIGNITITECNUCLEUS
Cash & Equivalents i₹1.99B₹501.60M
Total Current Assets i₹10.94B₹5.44B
Total Current Liabilities i₹2.49B₹2.83B
Long-Term Debt i₹132.35M₹8.80M
Total Shareholders Equity i₹9.63B₹8.14B
Retained Earnings i₹6.58B₹7.67B
Property, Plant & Equipment i₹68.79M₹470.30M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CIGNITITECNUCLEUS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCIGNITITECNUCLEUS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i71,64613,612
Average Daily Volume (90 Day) i63,40113,347
Shares Outstanding i27.30M26.33M
Float Shares i10.17M6.61M
% Held by Insiders i0.75%0.76%
% Held by Institutions i0.15%0.03%

Dividend Analysis & Yield Comparison: Cigniti Technologies vs Nucleus Software

MetricCIGNITITECNUCLEUS
Last 12-Month Dividend i₹0.00₹12.50
Last 12-Month Dividend Yield iN/A1.08%
3-Year Avg Annual Dividend i₹2.00₹11.67
3-Year Avg Dividend Yield i0.32%0.93%
3-Year Total Dividends i₹6.00₹35.00
Ex-Dividend DateNov 16, 2023Jul 11, 2025